ZA200306542B - 1-Aryl-or 1-alkylsulfonylbenzazole derivatives a 5-hydroxy-tryptamine-6 ligands. - Google Patents
1-Aryl-or 1-alkylsulfonylbenzazole derivatives a 5-hydroxy-tryptamine-6 ligands.Info
- Publication number
- ZA200306542B ZA200306542B ZA200306542A ZA200306542A ZA200306542B ZA 200306542 B ZA200306542 B ZA 200306542B ZA 200306542 A ZA200306542 A ZA 200306542A ZA 200306542 A ZA200306542 A ZA 200306542A ZA 200306542 B ZA200306542 B ZA 200306542B
- Authority
- ZA
- South Africa
- Prior art keywords
- tryptamine
- ligands
- aryl
- hydroxy
- alkylsulfonylbenzazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Diabetes (AREA)
- Addiction (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26342501P | 2001-01-23 | 2001-01-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200306542B true ZA200306542B (en) | 2005-11-21 |
Family
ID=23001722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200306542A ZA200306542B (en) | 2001-01-23 | 2003-08-21 | 1-Aryl-or 1-alkylsulfonylbenzazole derivatives a 5-hydroxy-tryptamine-6 ligands. |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US6509357B1 (ja) |
| EP (1) | EP1353904B9 (ja) |
| JP (1) | JP4208573B2 (ja) |
| KR (1) | KR20030068591A (ja) |
| CN (1) | CN1273450C (ja) |
| AR (1) | AR034203A1 (ja) |
| AT (1) | ATE312078T1 (ja) |
| AU (1) | AU2002251811B2 (ja) |
| BR (1) | BR0206633A (ja) |
| CA (1) | CA2435566A1 (ja) |
| DE (1) | DE60207815T2 (ja) |
| DK (1) | DK1353904T3 (ja) |
| EA (1) | EA006057B1 (ja) |
| ES (1) | ES2250638T3 (ja) |
| HU (1) | HUP0401009A3 (ja) |
| IL (1) | IL157059A0 (ja) |
| MX (1) | MXPA03006479A (ja) |
| NO (1) | NO20033300L (ja) |
| NZ (1) | NZ527051A (ja) |
| PL (1) | PL364568A1 (ja) |
| TW (1) | TW593278B (ja) |
| WO (1) | WO2002059088A1 (ja) |
| ZA (1) | ZA200306542B (ja) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1293072C (zh) * | 2001-04-20 | 2007-01-03 | 惠氏公司 | 作为5－羟色胺－6配体的杂环基氧基－、－硫代－和－氨基吲哚衍生物 |
| BR0209047A (pt) * | 2001-04-20 | 2004-08-10 | Wyeth Corp | Derivados de heterociclilalcóxi-, -alquiltio- e -alquilaminobenzazol como ligantes de 5-hidroxitriptamina-6 |
| EP1401813B1 (en) * | 2001-06-07 | 2007-02-07 | F. Hoffman-la Roche AG | New indole derivatives with 5-ht6 receptor affinity |
| WO2003068740A1 (en) * | 2002-02-14 | 2003-08-21 | Wyeth | Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands |
| KR100657056B1 (ko) * | 2002-06-05 | 2006-12-13 | 에프. 호프만-라 로슈 아게 | 중추 신경계 장애의 치료를 위한 5-ｈｔ6-수용체조절제로서 1-설폰일-4-아미노알콕시 인돌 유도체 |
| AU2003268117A1 (en) * | 2002-09-18 | 2004-04-08 | Eli Lilly And Company | Histamine h3 receptor antagonists, preparaton and therapeutic uses |
| DE60316180T2 (de) * | 2002-12-03 | 2008-05-29 | F. Hoffmann-La Roche Ag | Aminoalkoxyindol-derivate als 5-ht6-rezeptorliganden zur bekämpfung von zns-krankheiten |
| RU2347780C2 (ru) * | 2003-02-14 | 2009-02-27 | Уайт | Гетероциклил-3-сульфонилиндазолы в качестве лигандов 5-гидрокситриптамина-6 |
| US7135575B2 (en) | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
| SE0302760D0 (sv) * | 2003-10-20 | 2003-10-20 | Biovitrum Ab | New compounds |
| RU2006134021A (ru) | 2004-02-27 | 2008-04-10 | Ф.Хоффманн-Ля Рош Аг (Ch) | Производные гетероарил-конденсированного пиразола |
| EP1737865A1 (en) | 2004-02-27 | 2007-01-03 | F.Hoffmann-La Roche Ag | Fused derivatives of pyrazole |
| KR20060114022A (ko) | 2004-02-27 | 2006-11-03 | 에프. 호프만-라 로슈 아게 | 인다졸 유도체 및 그들을 함유하는 약학 조성물 |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| CA2883044C (en) * | 2004-10-08 | 2017-08-15 | Sdb Ip Holdings, Llc | Diaphragm valve with electronic pressure detection |
| ATE417830T1 (de) | 2004-11-02 | 2009-01-15 | Pfizer | Sulfonylbenzimidazolderivate |
| EP1931640A2 (en) * | 2005-08-15 | 2008-06-18 | Wyeth a Corporation of the State of Delaware | Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| CN101243088B (zh) | 2005-08-25 | 2011-06-29 | 霍夫曼-拉罗奇有限公司 | p38 MAP激酶抑制剂及使用它的方法 |
| PE20070427A1 (es) * | 2005-08-30 | 2007-04-21 | Novartis Ag | Compuestos derivados de benzimidazoles sustituidos como inhibidores de tirosina quinasas |
| CN101415685B (zh) | 2006-01-31 | 2011-08-24 | 阿雷生物药品公司 | 激酶抑制剂及其使用方法 |
| AU2007235499A1 (en) * | 2006-04-05 | 2007-10-18 | Wyeth | Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| WO2007120596A1 (en) * | 2006-04-12 | 2007-10-25 | Wyeth | DIHYDRO[1,4]DIOXINO[2,3-e]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS |
| EP2029550A2 (en) * | 2006-06-01 | 2009-03-04 | Wyeth a Corporation of the State of Delaware | 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands |
| US20090023925A1 (en) * | 2007-06-28 | 2009-01-22 | Wyeth | N'-(2-halobenzylidene)sulfonylhydrazides as intermediates in the manufacture of arylsulfonylindazoles |
| LT2624696T (lt) | 2010-10-06 | 2017-03-10 | Glaxosmithkline Llc | Benzimidazolo deriniai kaip pi3 kinazės inhibitoriai |
| US9663498B2 (en) | 2013-12-20 | 2017-05-30 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic compounds and their application in pharmaceuticals |
| WO2016004882A1 (en) | 2014-07-08 | 2016-01-14 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic derivatives and pharmaceutical applications thereof |
| JP7187449B2 (ja) | 2016-09-30 | 2022-12-12 | エピザイム，インコーポレイティド | Ｅｈｍｔ２阻害剤としての置換された融合二環式または三環式複素環化合物 |
| AU2018254577B2 (en) | 2017-04-21 | 2024-06-13 | Epizyme, Inc. | Combination therapies with EHMT2 inhibitors |
| BR112020009055A2 (pt) | 2017-11-06 | 2020-11-03 | Rapt Therapeutics, Inc. | moduladores de receptor de quimiocina para tratamento de câncer positivo para vírus epstein barr |
| CN112847099A (zh) * | 2021-03-08 | 2021-05-28 | 王佳丽 | 一种有效调节进给量实现自动切割的砂轮切割机 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2905877A1 (de) * | 1979-02-16 | 1980-08-28 | Boehringer Mannheim Gmbh | Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| JPH09506885A (ja) * | 1993-12-21 | 1997-07-08 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | ５ｈｔ▲下１ｄ▼（抗うつ作用）活性を有するインドール、インドリンおよびキノリン誘導体 |
| GB9416972D0 (en) | 1994-08-23 | 1994-10-12 | Smithkline Beecham Plc | Carbon side chain/indole/indolene |
| AU2242197A (en) * | 1996-01-09 | 1997-08-01 | Eli Lilly And Company | Benzimidzolyl neuropeptide y receptor antagonists |
| GB9600344D0 (en) | 1996-01-09 | 1996-03-13 | Lilly Co Eli | Benzimidzolyl neuropeptide y receptor antagonists |
| AU2139097A (en) * | 1996-03-01 | 1997-09-16 | Eli Lilly And Company | Methods of treating or preventing sleep apnea |
| JP3560986B2 (ja) | 1997-01-13 | 2004-09-02 | 山之内製薬株式会社 | ５―ｈｔ２ｃ受容体作用薬及びアミノアルキルインダゾール誘導体 |
| US6127380A (en) | 1997-02-18 | 2000-10-03 | American Home Products Corporation | 4-aminoalkoxy-1H-benzoimidazoles |
| US5872144A (en) | 1997-02-18 | 1999-02-16 | American Home Products Corporation | 4-aminoethoxyindazole derivatives |
| EA200001007A1 (ru) | 1998-03-31 | 2001-04-23 | Дюпон Фармасьютикалз Компани | Фармацевтические препараты для визуализации ангиогенных расстройств |
| GB9820113D0 (en) * | 1998-09-15 | 1998-11-11 | Merck Sharp & Dohme | Therapeutic agents |
| ES2288040T3 (es) * | 1998-12-18 | 2007-12-16 | Bristol-Myers Squibb Pharma Company | Medicamentos antagonistas del receptor de la vitronectina. |
| GB9902452D0 (en) * | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
| GB0019950D0 (en) * | 2000-08-12 | 2000-09-27 | Smithkline Beecham Plc | Compounds |
-
2001
- 2001-12-26 TW TW090132299A patent/TW593278B/zh not_active IP Right Cessation
-
2002
- 2002-01-18 DK DK02720837T patent/DK1353904T3/da active
- 2002-01-18 MX MXPA03006479A patent/MXPA03006479A/es active IP Right Grant
- 2002-01-18 ES ES02720837T patent/ES2250638T3/es not_active Expired - Lifetime
- 2002-01-18 EP EP02720837A patent/EP1353904B9/en not_active Expired - Lifetime
- 2002-01-18 CA CA002435566A patent/CA2435566A1/en not_active Abandoned
- 2002-01-18 KR KR10-2003-7009699A patent/KR20030068591A/ko not_active Application Discontinuation
- 2002-01-18 EA EA200300829A patent/EA006057B1/ru not_active IP Right Cessation
- 2002-01-18 PL PL02364568A patent/PL364568A1/xx not_active Application Discontinuation
- 2002-01-18 DE DE60207815T patent/DE60207815T2/de not_active Expired - Lifetime
- 2002-01-18 HU HU0401009A patent/HUP0401009A3/hu unknown
- 2002-01-18 AT AT02720837T patent/ATE312078T1/de not_active IP Right Cessation
- 2002-01-18 WO PCT/US2002/001950 patent/WO2002059088A1/en active IP Right Grant
- 2002-01-18 AU AU2002251811A patent/AU2002251811B2/en not_active Ceased
- 2002-01-18 JP JP2002559390A patent/JP4208573B2/ja not_active Expired - Fee Related
- 2002-01-18 BR BR0206633-5A patent/BR0206633A/pt not_active IP Right Cessation
- 2002-01-18 IL IL15705902A patent/IL157059A0/xx unknown
- 2002-01-18 CN CNB028067576A patent/CN1273450C/zh not_active Expired - Fee Related
- 2002-01-18 NZ NZ527051A patent/NZ527051A/en unknown
- 2002-01-22 AR ARP020100210A patent/AR034203A1/es not_active Application Discontinuation
- 2002-01-22 US US10/055,365 patent/US6509357B1/en not_active Expired - Fee Related
- 2002-12-09 US US10/314,726 patent/US6710069B2/en not_active Expired - Fee Related
-
2003
- 2003-07-22 NO NO20033300A patent/NO20033300L/no not_active Application Discontinuation
- 2003-08-21 ZA ZA200306542A patent/ZA200306542B/xx unknown
- 2003-10-28 US US10/695,490 patent/US20040092564A1/en not_active Abandoned
- 2003-10-29 US US10/696,433 patent/US6919354B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200306542B (en) | 1-Aryl-or 1-alkylsulfonylbenzazole derivatives a 5-hydroxy-tryptamine-6 ligands. | |
| IL162242A0 (en) | Azaindolylalkylamine derivatives as5-hydroxytryptamine-6 ligands | |
| HK1061621A1 (en) | A fencing. | |
| MXPA03008140A (es) | Amidas de acido benzofuran-2-carboxilico sustituidas. | |
| GB0012054D0 (en) | Ligands | |
| AU149656S (en) | A cart-housing | |
| HK1050890A1 (en) | Aminomethyl -phenyl-cyclohexanone derivatives. | |
| MXPA03008394A (es) | Derivados de biuretano. | |
| ZA200404185B (en) | A sawmill. | |
| HK1059781A1 (en) | New phenylpiperazines. | |
| GB0115841D0 (en) | Ligand | |
| ZA200203813B (en) | A tomb. | |
| GB2372253B (en) | A render | |
| GB0121122D0 (en) | D.a.r.t | |
| ZA200204263B (en) | A bed. | |
| ZA200205529B (en) | A conveyor. | |
| ZA200203337B (en) | A cooking bag. | |
| ZA200208989B (en) | A cooker. | |
| ZA200200034B (en) | A food substance. | |
| ZA200002483B (en) | A wind-dryer. | |
| ZA200201235B (en) | A study aid. | |
| GB0024022D0 (en) | S.A.R.E. Energynet | |
| ZA200205431B (en) | A medicament. | |
| ZA200300453B (en) | A belt. | |
| AU147226S (en) | A T-shirt |